Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07273448Enrolling By Invitation

Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation

Role: lead

NCT07247877Enrolling By Invitation

Research on Using Small-for-size Grafts for Auxiliary Liver Transplantation in the Treatment of Portal Hypertension

Role: lead

NCT06513780Recruiting

A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation

Role: lead

All 3 trials loaded